SLC9A1 and glioma: This has been most thoroughly studied regarding NHE in melanoma cells, though gliomas similarly possess increased NHE1 activity versus their non-transformed counterparts (McLean et al., 2000) with specific microdomain localization (Willoughby et al., 2005).